Inhibrx Reports Significant Losses and Plummeting Revenue

Inhibrx, Inc. (INBX) reveals a fourth-quarter loss of $47.87 million with earnings per share at -$3.09. Revenue has dropped drastically by 93.9%, raising concerns for investors.

Date: 17-03-2025

AI Rating: 4

Overview of Earnings Performance

Inhibrx, Inc. reported a significant loss for the fourth quarter, amounting to -$47.87 million, which translates to an earnings per share (EPS) of -$3.09. This indicates a substantial improvement from the previous year's loss of -$93.60 million, which had an EPS of -$6.93. However, this figure still reflects ongoing negative performance.

Revenue Decline

The company's revenue faced a dramatic decline, falling by 93.9% to just $0.10 million, a marked decrease from $1.63 million the prior year. Such a steep drop in revenue is a critical point of concern for investors, as it raises questions about the operational efficiency and market conditions affecting the company.

Analysis of Key Metrics

The information regarding earnings per share (EPS) shows that while there was a reduction in losses compared to the previous period, the figures remain in negative territory. Additionally, the revenue decline reflects a critical downturn, which could negatively impact investor confidence.

Stocks: INBX